"Diverse representation in clinical trials is a problem around the world. Clinical trials are needed to define the safety and efficacy of new therapies for patients. However, people of different ethnic and racial backgrounds may respond differently to the same drugs. That’s why it is so important to have a diverse racial and ethnic patient population. Unfortunately, there is currently significant under-representation of BIPOC (Black, Indigenous, People of Color) participants due to multiple barriers including mistrust, lack of access..."
- by Sheba George and colleagues in the American Journal of Public Health.
An up-and-coming gene therapy for blood disorders. A new class of medications for cystic fibrosis. Increased access to telemedicine. These are some of the innovations that will enhance healing and change healthcare in the coming year, according to a distinguished panel of clinicians and researchers from Cleveland Clinic.